Oppenheimer Starts Catalyst Pharmaceutical Partners (CPRX) at Outperform, 'DMD Launch to Outpace Expectations'
Tweet Send to a Friend
(Updated - December 20, 2023 4:03 PM EST)
Oppenheimer analyst Leland Gershell initiates coverage on Catalyst Pharmaceutical Partners (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell initiates coverage on Catalyst Pharmaceutical Partners (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
